Finance

Lists
P8A:SGX
Cordlife Group Ltd
0,12 SGD
0,00%
(0,00) 1D
19 ოქტ, 13:09:02 GMT+8  ·   SGD
All symbols
SymbolPriceChange% Change
Generating top insights for P8A...
Open
0,12 SGD
High
0,12 SGD
Low
0,12 SGD
Mkt. cap
32,64 მლნ.
Avg. vol.
1,22 ათ.
Volume
10,00 ათ.
52-wk high
0,26 SGD
52-wk low
0,10 SGD
EPS
-0,04 SGD
Shares outstanding
267,53 მლნ.
No. of employees
111
Open
0,12 SGD
High
0,12 SGD
Low
0,12 SGD
Mkt. cap
32,64 მლნ.
Avg. vol.
1,22 ათ.
Volume
10,00 ათ.
52-wk high
0,26 SGD
52-wk low
0,10 SGD
EPS
-0,04 SGD
Shares outstanding
267,53 მლნ.
No. of employees
111
News stories
From web sources and news partners
www.marketscreener.com
www.marketscreener.com
·
8 წუთის წინ
Nasdaq 100 Climbs on AI Trade Revival After Rout
Simply Wall Street
Simply Wall Street
·
27 წუთის წინ
Top Nuclear Stocks For October 2026
Profile
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012. Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services. Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn. In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
About Cordlife Group Ltd
CEOიუ პანგ ფაი
Employees111
Founded2 მაი. 2001
Headquarters-
SectorHealth care provider
Previous reportsAll values in SGD
Loading Previous Earnings...
Revenue
Net income
All values in SGD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
10,21 მლნ.
9,46 მლნ.
8,99 მლნ.
8,30 მლნ.
Cost of goods sold
4,16 მლნ.
4,05 მლნ.
3,78 მლნ.
3,44 მლნ.
Cost of revenue
4,16 მლნ.
4,05 მლნ.
3,78 მლნ.
3,44 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9,42 მლნ.
10,52 მლნ.
7,60 მლნ.
6,41 მლნ.
Operating expense
9,29 მლნ.
10,41 მლნ.
7,47 მლნ.
6,36 მლნ.
Total operating expenses
13,45 მლნ.
14,46 მლნ.
11,25 მლნ.
9,80 მლნ.
Operating income
-3,24 მლნ.
-5,00 მლნ.
-2,26 მლნ.
-1,50 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
-2,33 მლნ.
-4,30 მლნ.
-1,70 მლნ.
-873,00 ათ.
EBT excluding unusual items
-2,33 მლნ.
-4,38 მლნ.
-1,70 მლნ.
-873,00 ათ.
Income tax expense
149,00 ათ.
1,26 მლნ.
19,00 ათ.
64,00 ათ.
Effective tax rate
-6,39%
-29,22%
-1,12%
-7,33%
Other operating expenses
-133,00 ათ.
-111,00 ათ.
-132,00 ათ.
-54,00 ათ.
Net income
-2,48 მლნ.
-5,55 მლნ.
-1,72 მლნ.
-936,00 ათ.
Net profit margin
-24,32%
-58,72%
-19,13%
-11,28%
Earnings per share
-
-
-
-
Interest and investment income
642,00 ათ.
589,00 ათ.
565,00 ათ.
587,00 ათ.
Interest expense
-27,00 ათ.
-34,00 ათ.
-28,00 ათ.
-77,00 ათ.
Net interest expenses
615,00 ათ.
555,00 ათ.
537,00 ათ.
510,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,17 მლნ.
-4,29 მლნ.
-1,33 მლნ.
-621,00 ათ.
Gain or loss from assets sale
1,00 ათ.
220,00 ათ.
5,00 ათ.
4,00 ათ.
AI content may include mistakes. Learn more
Google აპები